Spots Global Cancer Trial Database for pleomorphic liposarcoma

Every month we try and update this database with for pleomorphic liposarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall	NCT03651375	Sarcoma Fibrosarcoma Leiomyosarcoma Liposarcoma Myosarcoma Histiocytic Sar... Synovial Sarcom... Lymphangiosarco... Malignant Perip... Myxofibrosarcom... Myxoid Liposarc... Undifferentiate... Pleomorphic Lip... Undifferentiate... Dedifferentiate... Pleomorphic Rha... Malignant Trito...	Sequential chem... Hypofractionate...	18 Years - 100 Years	Maria Sklodowska-Curie National Research Institute of Oncology
Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated Liposarcoma	NCT04979442	Dedifferentiate...	RAIN-32 Trabectedin	18 Years -	Rain Oncology Inc
Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients	NCT02275286	Liposarcoma, My... Sarcoma, Soft T... Leiomyosarcoma Liposarcoma Pleomorphic Lip...	Trabectedin Radiotherapy	18 Years -	Grupo Espanol de Investigacion en Sarcomas
Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients	NCT02275286	Liposarcoma, My... Sarcoma, Soft T... Leiomyosarcoma Liposarcoma Pleomorphic Lip...	Trabectedin Radiotherapy	18 Years -	Grupo Espanol de Investigacion en Sarcomas
Detection of Circulating Tumor Cells in Patients With Sarcomas	NCT02983539	Leiomyosarcoma Pleomorphic Lip... Synovial Sarcom... Liposarcoma		18 Years - 70 Years	AC Camargo Cancer Center
Detection of Circulating Tumor Cells in Patients With Sarcomas	NCT02983539	Leiomyosarcoma Pleomorphic Lip... Synovial Sarcom... Liposarcoma		18 Years - 70 Years	AC Camargo Cancer Center
Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery	NCT02500797	Locally Advance... Locally Advance... Locally Advance... Locally Advance... Metastatic Bone... Metastatic Lipo... Metastatic Soft... Metastatic Undi... Metastatic Unre... Pleomorphic Lip... Stage III Bone ... Stage III Soft ... Stage IV Bone S... Stage IV Soft T... Stage IVA Bone ... Stage IVB Bone ... Unresectable Bo... Unresectable De... Unresectable Li... Unresectable Ma... Unresectable So...	Ipilimumab Laboratory Biom... Nivolumab Quality-of-Life...	18 Years -	National Cancer Institute (NCI)
Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall	NCT03651375	Sarcoma Fibrosarcoma Leiomyosarcoma Liposarcoma Myosarcoma Histiocytic Sar... Synovial Sarcom... Lymphangiosarco... Malignant Perip... Myxofibrosarcom... Myxoid Liposarc... Undifferentiate... Pleomorphic Lip... Undifferentiate... Dedifferentiate... Pleomorphic Rha... Malignant Trito...	Sequential chem... Hypofractionate...	18 Years - 100 Years	Maria Sklodowska-Curie National Research Institute of Oncology

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: